Showing results (671-680 of 840) with videos related to
Sort By:
Pageof 84
Cancer|October 17, 2007
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska NativesDavid K Espey, Xiao-Cheng Wu, Judith Swan, et al.American Journal of Clinical Oncology|June 7, 2007
A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanomaSvetomir N Markovic, Vera J Suman, Ravi A Rao, et al.Archives of Osteoporosis|June 11, 2024
Evaluating compliance with the care standard of proactively assessing bone health in patients with diabetes: a pilot audit of practice across Asia by the Asia Pacific Consortium on Osteoporosis (APCO)M Chandran, N Aftab, A Amin, et al.Urology|March 10, 2023
The Impact of Within-Consultation and Preconsultation Decision Aids for Localized Prostate Cancer on Patient Knowledge: Results of a Patient-Level Randomized TrialDaniel D Joyce, Jon C Tilburt, Joel E Pacyna, et al.Cancer Immunology Research|March 12, 2025
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal AdenocarcinomaZoe C Schmiechen, Hezkiel A Nanda, Adam L Burrack, et al.The New England Journal of Medicine|June 7, 2016
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 YearsPaul E Goss, James N Ingle, Kathleen I Pritchard, et al.Science (New York, N.Y.)|June 25, 2026
Constraining an exoplanet's magnetic field using star-planet interactionsD Revilla, P J Amado, R Luque, et al.TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|October 13, 2009
Genetic map construction and QTL mapping of resistance to blackleg (Leptosphaeria maculans) disease in Australian canola (Brassica napus L.) cultivarsS Kaur, N O I Cogan, G Ye, et al.Science Immunology|June 26, 2026
Treg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancerZoe C Schmiechen, Eduardo Cruz-Hinojoza, Audrey L Hilk, et al.Cancer Research|January 28, 2010
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancerEvanthia Galanis, Lynn C Hartmann, William A Cliby, et al.Pageof 84